NCT02515201

Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children

Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children With Intestinal Failure

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Hospital de Clinicas de Porto Alegre · Academic / Other
• Sex: All
• Age: 30 Days – 14 Years
• Healthy volunteers: Not accepted

Summary

Clinical trial, that aim is evaluation of the use of taurolidine and heparin in the prevention of bloodstream infection in venous catheter in children with intestinal failure.

Detailed description

Will be collected data about sociodemographics : date of birth, hospitalization and which is use (taurolidine or heparin), sex, underlying disease and associated co-morbidities. About central venous catheter will be collect: catheter type in each period, the number of lumens, date of insertion of each catheter usage time, reason for removal of the catheter insertion site and catheter material (silicone or polyurethane ). Data relating to parenteral nutrition will also be collected: osmolarity of parenteral nutrition, infusion time every 24 hours and concentration of glucose parenteral nutrition bag. It will be used for aseptic handling technique of the solutions, as well as for handling the connections of the central catheter. For preparation and administration of taurolidine and heparin is used an operations manual that was made for the authors. Patients are divided into two groups: taurolidine or heparin.

Conditions

• Catheter-Related Infections

Interventions

Type	Name	Description
DRUG	Taurolidine	taurolidine in central catheter lumen
DRUG	Heparin	heparin in central venous catheter lumen

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-03-01
• Completion: 2016-12-01
• First posted: 2015-08-04
• Last updated: 2015-08-04